{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:05:27Z","timestamp":1792670727371,"version":"4.5.0"},"reference-count":29,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,4,8]],"date-time":"2009-04-08T00:00:00Z","timestamp":1239148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> A beta\u2010blocker is recommended for primary prophylaxis of variceal bleeding; however, only one\u2010third have hepatic venous pressure gradient (HVPG) response. The role of addition of isosorbide\u20105\u2010mononitrate (ISMN) to beta\u2010blocker and benefits of HVPG\u2010guided \u2018<jats:italic>a la carte<\/jats:italic>\u2019 approach remain unclear.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To determine the benefits of HVPG\u2010guided pharmacotherapy in primary prophylaxis of variceal bleeding using beta\u2010blocker and ISMN.<\/jats:p><jats:p><jats:bold>Patients and methods\u2002<\/jats:bold> Consecutive patients of cirrhosis, with high\u2010risk varices, with no previous variceal bleeding were included. After baseline HVPG, patients received incremental propranolol to achieve HR of 55\/min. After one\u2010month, HVPG was repeated to determine response (&lt;12\u2003mmHg or \u226520% reduction). ISMN was added in nonresponders and HVPG repeated. Patients were followed up for 24\u2003months.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Of 56 patients (age 47\u2003\u00b1\u200313, males 79%) from 89 eligible patients, 21 (38%) responded to beta\u2010blocker alone. Six additional patients responded to combination. Thus, overall 48% (27\/56) patients responded. Variceal bleeding occurred in seven of 56 (13%) patients [one of 27 (4%) responder, five of 23 (22%) nonresponders and one of six (17%) with unknown response; <jats:italic>P<\/jats:italic>\u2003=\u2003N.S.]. The actuarial probability of variceal bleeding at median 24\u2003months was 4% in responders and 22% in nonresponders (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). Ten (18%) patients developed adverse effects to propranolol and six of 35 (17%) to nitrates requiring dose reduction. Risk factors of variceal bleed were grade IV varices and haemodynamic nonresponse.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> For primary prophylaxis, a beta\u2010blocker is effective in 38% and addition of ISMN raises the response rate to about half of patients. The HVPG\u2010guided \u2018<jats:italic>a la carte<\/jats:italic>\u2019 approach may be considered for these patients.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2009.04015.x","type":"journal-article","created":{"date-parts":[[2009,4,8]],"date-time":"2009-04-08T06:47:37Z","timestamp":1239173257000},"page":"48-60","source":"Crossref","is-referenced-by-count":22,"title":["Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with \u2018high\u2010risk\u2019 varices"],"prefix":"10.1111","volume":"30","author":[{"given":"P.","family":"SHARMA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"KUMAR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. C.","family":"SHARMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. K.","family":"SARIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6,15]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33419"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50385"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20339"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2007.12.004"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.05.009"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21907"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-007-9010-9"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007133"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-10-869"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)05406-2"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310210"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50211"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)91168-6"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.19322"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00453.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.08729.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01391.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360611"},{"key":"e_1_2_7_20_2","first-page":"442","article-title":"Ammonia tolerance in the diagnosis of esophageal varices. A comparison of endoscopic, radiologic, and biochemical techniques","volume":"70","author":"Conn HO","year":"1967","journal-title":"J Lab Clin Med"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20062"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.9811062"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50274"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360606"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01564.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840110212"},{"key":"e_1_2_7_27_2","first-page":"1357","article-title":"Effects of 5\u2010isosorbide mononitrate and propranolol on subclinical hepatic encephalopathy and renal function in patients with liver cirrhosis","volume":"49","author":"Silva G","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(84)90602-1"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360612"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.26288"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2009.04015.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2009.04015.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T19:51:06Z","timestamp":1697226666000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2009.04015.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1365-2036.2009.04015.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04015.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,15]]}}}